申请人:Lin Chu-Chung
公开号:US20060036093A1
公开(公告)日:2006-02-16
This invention relates to treating inflammatory and immune diseases with certain pyrimidinone compounds that bind to CXCR3 receptors. The pyrimidinone compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
这项发明涉及使用与CXCR3受体结合的某些嘧啶酮化合物治疗炎症和免疫性疾病。这些嘧啶酮化合物由下面所示的公式(I)覆盖。每个变量在说明书中有定义。